|
|
| Research article summary (published 29 Jun 2009): |
Update on abuse-resistant and abuse-deterrent approaches to opioid formulations.
Full Abstract
The number of opioid analgesic prescriptions has increased since 1990. Opioids are being prescribed for longer periods of time for both cancer- and noncancer-associated moderate to severe chronic pain. Concurrent with the increased prescribing of opioids has been an increase in their diversion from prescribed use and their abuse; frequently, this abuse occurs after the opioid analgesic has been physically or chemically manipulated to increase the concentration or bioavailability of the active ingredient. Formulations of opioids have been designed to resist the extraction of the active opioid from prescribed products through the incorporation of physical barriers or to deter the reinforcing effects of opioids through the incorporation of antagonists or other ingredients that only become active when the analgesic is used improperly. However, none of these formulations are currently commercially available in the United States. This paper describes the formulations now under development and their potential clinical utility and impact on society. These emerging opioid formulations designed to reduce the risk of misuse and/or abuse may be useful to physicians in meeting the important goals of maximizing pain relief and minimizing prescription opioid abuse.
Author information
Author/s: Webster, Lynn (L);
Affiliation: Lifetree Clinical Research and Pain Clinic, Salt Lake City, Utah 84106, USA. lynnw(-atsign-)lifetreepain.com
Journal and publication information
Publication Type: Journal Article; Review
Journal: Pain medicine (Malden, Mass.) (Pain Med), published in United States. (Language: eng)
Reference: 2009-Jul; vol 10 Suppl 2 (issue ) : pp S124-33
Dates: Created 2009/08/20; Completed 2009/11/02;
PMID: 19691683, status: MEDLINE (last retrieved date: 11/2/2009)
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MeSH Headings (categories) shown below.
Note: Bold headings indicate primary MeSH headings or qualifiers.
Associated Chemicals: Analgesics, Opioid (0) ; Dosage Forms (0)Related articles
These are the most related articles currently in our database:
- Scientists probe ways to curb opioid abuse without hindering pain treatment.
7 May 2007 - Issues in opioid management.
27 Feb 2005 - Collaborative practice. Undertreatment of pain and fears of addiction in pediatric chronic pain patients: how do we stop the problem?
30 Dec 2005 - Regulated analgesics and pain control.
13 May 1996 - Opioids in the treatment of chronic pain: legal framework and therapeutic indications and limitations.
29 Apr 2006 - Abuse deterrence focus of upcoming opioid formulations.
28 Feb 2008 - Appropriate and responsible use of opioids in chronic non-cancer pain.
30 Dec 2002 - Emergency management of chronic pain and drug-seeking behavior: an alternate perspective.
7 Nov 2007 - Contract work.
30 Mar 2008 - Foundations of opioid risk management.
30 Jan 2007
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a larger map of 100+ related articles.